Mayank Bansal, CFA
Mayank Bansal is a CFA Charterholder and heads the Equity Research team at Kapitales Research, with over 5 years of experience analysing global equity markets. He leads fundamental, data-driven research combining rigorous financial analysis with macro trends.
3 ASX Stocks in Focus as Market Updates Drive Investor Attention on Monday
Highlights:
The Australian share market is witnessing notable movements across several sectors, with company announcements providing fresh insights into business performance, investor activity and market sentiment. On 2 November 2026, developments involving three ASX-listed companies attracted attention, ranging from a response to an exchange price query and quarterly revenue growth to changes in substantial shareholdings. These updates offer investors a closer look at the latest corporate developments and factors influencing trading activity.
Stocks in Focus:
ASX Market Updates on 2 November 2026
Australian investors are assessing a range of company announcements spanning medical technology, building products and nuclear technology. The latest disclosures provide insight into recent share price movements, quarterly operating performance and institutional investment activity. The announcements from the three companies highlight developments that could influence market sentiment and investor assessments.
4DMedical Responds to ASX Price Query
4DMedical Limited responded to an Australian Securities Exchange (ASX) price query on 2 November 2026 following significant trading activity in its shares. The exchange raised concerns after the company’s share price declined from AU$3.28 at the close of trading on 29 October to AU$2.41 on 30 October, alongside a substantial increase in trading volume. In its response, the company stated that it was not aware of any undisclosed information that could explain the recent movements. Instead, 4DMedical suggested that an increase in short interest may have contributed to the trading activity. The company also confirmed that it was complying with ASX Listing Rules, particularly its continuous disclosure obligations. The response was approved by the Chair and Chief Executive Officer on behalf of the board.
Reece Reports First-Quarter FY27 Revenue Growth
Reece Limited released its first-quarter FY27 trading update on 30 October 2026, reporting sales revenue of AU$2,510 million, representing a 4.3% increase compared with the corresponding period last year. Revenue growth reached 8.7% on a constant currency basis. Australia and New Zealand continued to deliver strong performance, with sales increasing 12.8%, supported by higher volumes and inflation. In the United States, sales grew 5.6%, driven by network expansion and modest inflation, while like-for-like sales increased 2.4%.
Chairman and Chief Executive Officer Peter Wilson highlighted continued momentum in ANZ but noted that the US residential construction market remained subdued. Management expects a strong first half in ANZ but anticipates continued challenges in the US. The company also expressed caution regarding the second half of FY27 due to broader macroeconomic uncertainty. Separately, the company’s annual general meeting results showed that its remuneration report received a first strike after more than 25% of votes were cast against it.
Silex Systems Reports Reduced Substantial Holding
Silex Systems Limited disclosed a change in substantial shareholding through a Form 604 notice dated 30 October 2026. Van Eck Associates Corporation and its associates reported reducing their voting interest in the company from 8.54% to 7.53%. Their total relevant voting interests declined from 23,679,491 shares to 20,995,872 shares. The disclosed transactions included purchases and sales involving VanEck Uranium and Nuclear ETFs and the VanEck Uranium and Nuclear Technologies UCITS ETF between July and October 2026. The latest transactions recorded on 28 October involved sales of shares at AU$3.53. Following the changes, Van Eck Associates Corporation retained a substantial holding in Silex Systems, with interests held across multiple investment funds.
Conclusion
The announcements provide investors with updates on corporate disclosure, operating performance and institutional ownership. While the companies operate in different sectors, their latest disclosures offer useful insights into the developments shaping their respective businesses and market activity.
Note: All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au